Medical News

RSS

Alcohol consumption interferes with sleep homeostasis

Researchers from the University of Missouri School of Medicine have found that drinking alcohol to fall asleep interferes with sleep homeostasis, the body's sleep-regulating mechanism.

11 Dec 2014

New study reveals how COX-2 inhibitors can increase risk of heart attack in arthritis patients

A class of drug for treating arthritis - all but shelved over fears about side effects - may be given a new lease of life, following the discovery of a possible way to identify which patients should avoid using it.

11 Dec 2014

Silvia Jurisson recognized as AAAS Fellow for contributions to cancer research

Nuclear medicine is the branch of medicine that uses radioactive materials to provide diagnostics and treatments for cancer. Often, standard protocols involve using radioactive isotopes developed to image as well as weaken cancer cells in the body. With more than 30 years of research in radiopharmaceutical chemistry, Silvia Jurisson, a researcher at the University of Missouri, is a world-renowned scientist who continues to develop breakthrough materials used in the detection and treatment of cancer.

11 Dec 2014

Progesterone treatment shows no clinical benefits in severe TBI patients

A study concluded that after five days of treatment with a novel formulation of progesterone acutely administered to patients with severe traumatic brain injury (TBI), showed no clinical benefits.

11 Dec 2014

$Golden Jubilee National Hospital first to use revolutionary technology in rib fracture surgery$

Golden Jubilee National Hospital first to use revolutionary technology in rib fracture surgery

The Golden Jubilee National Hospital recently became the first hospital in Scotland to use a revolutionary new technology on a patient suffering from a severe rib fracture.

11 Dec 2014

$Using Refractory Metals in Cancer Treatments$

Using Refractory Metals in Cancer Treatments

This interview discusses how refractory metals can be used in cancer treatments.

From H.C. Starck Solutions 10 Dec 2014

Carboplatin and paclitaxel show promise for advanced thymic carcinoma

A multicentre, phase II study of carboplatin and paclitaxel in chemotherapy-naïve patients with advanced thymic carcinoma has shown that the treatment has promising efficacy compared with standard anthracycline-based chemotherapy.

10 Dec 2014

PD-L1 expression tied to favourable prognosis in SCLC

Programmed death-ligand 1 is expressed by around 70% of small-cell lung cancers and is associated with favourable patient outcomes, Japanese researchers report.

10 Dec 2014

ECT improves general neurocognitive function in bipolar patients

A randomised trial shows that electroconvulsive therapy improves overall neurocognition in patients with treatment-resistant bipolar depression.

10 Dec 2014

Cerebellar cortical volume reduction specific to schizophrenia

Reduced cerebellar cortical volume occurs only in patients with schizophrenia, rather than all those with psychosis, say researchers.

10 Dec 2014

UTHealth opens Trauma and Grief Center for Youth

Children who are having difficulty processing trauma or loss can now turn to the Trauma and Grief Center for Youth at The University of Texas Health Science Center at Houston.

10 Dec 2014

Reductions in government healthcare spending in the EU linked to increased maternal mortality rates

Reductions in government healthcare spending in the European Union are associated with increased maternal mortality rates, suggests a new paper published today (10 December) in BJOG: An International Journal of Obstetrics and Gynaecology. However, if skilled birth attendants are in place, the association disappears, highlighting the potential importance of maternal care, finds the research.

10 Dec 2014

Enzymatic activity essential for vision may provide target for drug transport

Researchers at Case Western Reserve University School of Medicine have uncovered the mechanism that enables the enzyme Lecithin: retinol acyltransferase (LRAT) to store vitamin A--a process that is indispensable for vision.

10 Dec 2014

Arrhythmia patients who manage lifestyle factors more likely to have long-term survival

Patients suffering from the world's most common heart rhythm disorder can have their long-term outcomes significantly improved with an aggressive management of their underlying cardiac risk factors, according to University of Adelaide researchers.

10 Dec 2014

Simple supplement could reduce heart disease in individuals born with low birth weight

A simple supplement could be a safe and cost-effective way of reducing heart disease in individuals born with a low birth weight, suggests research from the University of Cambridge. The study, carried out in rats, also raises the possibility of developing a blood test to indicate how much damage there is in the aortas of these individuals.

10 Dec 2014

Novo Nordisk introduces new initiative to support healthy lifestyle programming in New Jersey area

Novo Nordisk today announced the launch of the Community Health Collaborative, a new initiative to support and expand healthy lifestyle programming in the Trenton, New Jersey area.

From Novo Nordisk 10 Dec 2014

Standardized set of measurements may help identify malnutrition among young children

Using a standardized set of measurements will help health professionals more accurately diagnose malnutrition among children ages 1 month to 18 years, as well as improve their treatment, according to a new joint statement from the Academy of Nutrition and Dietetics and the American Society for Parenteral and Enteral Nutrition.

10 Dec 2014

Prolongz drug achieves No. 1 spot in the personal care category

Prolongz, the all-natural FDA registered over-the-counter homeopathic drug that helps in the prevention of premature ejaculation, has been ranked No. 1 in the personal care category for July, August and September of 2014 by the Jordan Whitney Greensheet.

10 Dec 2014

Alizé Pharma completes two Phase I clinical trials of AZP-531 in healthy volunteers, obese subjects

Alizé Pharma SAS, an Alizé Pharma group company specialized in the development of biopharmaceuticals to treat metabolic disorders and rare diseases, announces today the completion of two Phase I clinical trials with its unacylated ghrelin analog AZP-531 in 76 healthy volunteers and overweight or obese subjects.

10 Dec 2014

Mylan announces U.S. launch of Celecoxib Capsules

Mylan Inc. today announced the U.S. launch of its Celecoxib Capsules, 50 mg, 100 mg, 200 mg, and 400 mg, one of the first available generic versions of Pfizer's Celebrex Capsules, which is indicated for the relief of the signs and symptoms of osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis, and for the management of acute pain in adults.

10 Dec 2014

Medical News

Alcohol consumption interferes with sleep homeostasis

New study reveals how COX-2 inhibitors can increase risk of heart attack in arthritis patients

Silvia Jurisson recognized as AAAS Fellow for contributions to cancer research

Progesterone treatment shows no clinical benefits in severe TBI patients

Golden Jubilee National Hospital first to use revolutionary technology in rib fracture surgery

Using Refractory Metals in Cancer Treatments

Carboplatin and paclitaxel show promise for advanced thymic carcinoma

PD-L1 expression tied to favourable prognosis in SCLC

ECT improves general neurocognitive function in bipolar patients

Cerebellar cortical volume reduction specific to schizophrenia

UTHealth opens Trauma and Grief Center for Youth

Reductions in government healthcare spending in the EU linked to increased maternal mortality rates

Enzymatic activity essential for vision may provide target for drug transport

Arrhythmia patients who manage lifestyle factors more likely to have long-term survival

Simple supplement could reduce heart disease in individuals born with low birth weight

Novo Nordisk introduces new initiative to support healthy lifestyle programming in New Jersey area

Standardized set of measurements may help identify malnutrition among young children

Prolongz drug achieves No. 1 spot in the personal care category

Alizé Pharma completes two Phase I clinical trials of AZP-531 in healthy volunteers, obese subjects

Mylan announces U.S. launch of Celecoxib Capsules

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

AI-powered analytics and experimental validation

Latest News